Robin Carson
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 33
- Multiple Myeloma Research and Treatments 30
- Chronic Myeloid Leukemia Treatments 4
- Oncology 14
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 5
- Co-authors
- Pieter Sonneveld (9 shared papers)María‐Victoria Mateos (8 shared papers)Andrew Spencer (8 shared papers)Meral Beksaç (6 shared papers)Tahamtan Ahmadi (5 shared papers)Katja Weisel (4 shared papers)Meletios Α. Dimopoulos (10 shared papers)Xiang Qin (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (7 papers)Annals of Hematology (4 papers)HemaSphere (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Robin Carson
32 papers receiving 284 citations
Peers
Comparison fields: 5 of 32
- Hematology 218
- Oncology 126
- Genetics 26
- Molecular Biology 109
- Radiology, Nuclear Medicine and Imaging 24
Countries citing papers authored by Robin Carson
This map shows the geographic impact of Robin Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Carson more than expected).
Fields of papers citing papers by Robin Carson
This network shows the impact of papers produced by Robin Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Carson. The network helps show where Robin Carson may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Carson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 74 | |
| 2 | 2019 | 31 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 15 | |
| 5 | 2024 | 14 | |
| 6 | 2020 | 13 | |
| 7 | 2020 | 12 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2015 | 9 | |
| 12 | 2019 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 4 |
About Robin Carson
Robin Carson is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Infectious Diseases, having authored 34 papers that have together received 290 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (5 papers), HIV/AIDS drug development and treatment (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Hematology (218 citations), Oncology (126 citations), Genetics (26 citations), Molecular Biology (109 citations) and Radiology, Nuclear Medicine and Imaging (24 citations). Robin Carson has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Pieter Sonneveld, María‐Victoria Mateos, Andrew Spencer, Meral Beksaç, Tahamtan Ahmadi, Katja Weisel, Meletios Α. Dimopoulos, Xiang Qin, Jodi Carey and Ivan Špıčka. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Hematology, HemaSphere and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.